These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1985820)

  • 1. Immunologic aspects of carbamazepine treatment in epileptic patients.
    Pacifici R; Paris L; Di Carlo S; Pichini S; Zuccaro P
    Epilepsia; 1991; 32(1):122-7. PubMed ID: 1985820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of phenytoin and carbamazepine treatment on nonspecific immunological reactivity in epilepsy].
    Członkowska A; Niedzielska K; Korlak J
    Neurol Neurochir Pol; 1981; 15(3):297-302. PubMed ID: 7312107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary immunoglobulin concentrations in patients with epilepsy treated with carbamazepine.
    Gilhus NE; Strandjord RE; Aarli JA
    Acta Neurol Scand; 1980 Nov; 62(5):300-4. PubMed ID: 7468153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients.
    Lenti C; Masserini C; Peruzzi C; Guareschi Cazzullo A
    Ital J Neurol Sci; 1991 Feb; 12(1):87-91. PubMed ID: 2013529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients.
    Başaran N; Hincal F; Kansu E; Ciğer A
    Int J Immunopharmacol; 1994 Dec; 16(12):1071-7. PubMed ID: 7705969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum of concentrations of immunoglobulins in patients with epilepsy treated with carbamazepine.
    Strandjord RE; Johannessen SI; Aarli JA
    Acta Neurol Scand; 1980 Apr; 61(4):260-3. PubMed ID: 6769290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin abnormalities in epileptic patients treated with diphenylhydantoin.
    Yabuki S; Nakaya K
    Folia Psychiatr Neurol Jpn; 1976; 30(2):93-109. PubMed ID: 971887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of carbamazepine on serum immunoglobulin concentrations.
    Gilhus NE; Strandjord RE; Aarli JA
    Acta Neurol Scand; 1982 Aug; 66(2):172-9. PubMed ID: 7136483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine effects on mononuclear blood cells in epileptic patients.
    Gilhus NE; Matre R
    Acta Neurol Scand; 1986 Sep; 74(3):181-5. PubMed ID: 3491486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulating properties of carbamazepine in mice.
    Pacifici R; Di Carlo S; Bacosi A; Pichini S; Zuccaro P
    Int J Immunopharmacol; 1992 May; 14(4):605-11. PubMed ID: 1521928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
    Epilepsia; 1998 Sep; 39(9):952-9. PubMed ID: 9738674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic aspects of vigabatrin treatment in epileptic children.
    Pacifici R; Zuccaro P; Iannetti P; Raucci U; Imperato C
    Epilepsia; 1995 Apr; 36(4):423-6. PubMed ID: 7607123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid function with antiepileptic drugs.
    Isojärvi JI; Pakarinen AJ; Myllylä VV
    Epilepsia; 1992; 33(1):142-8. PubMed ID: 1733749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine.
    Svalheim S; Mushtaq U; Mochol M; Luef G; Rauchenzauner M; Frøland SS; Taubøll E
    Acta Neurol Scand Suppl; 2013; (196):11-5. PubMed ID: 23190286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced IgA deficiency in epileptic patients.
    Aarli JA
    Arch Neurol; 1976 Apr; 33(4):296-9. PubMed ID: 1259644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine: effect on IgG subclasses in epileptic patients.
    Gilhus NE; Lea T
    Epilepsia; 1988; 29(3):317-20. PubMed ID: 3371285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy.
    Aarli JA
    Acta Neurol Scand; 1976 Nov; 54(5):423-30. PubMed ID: 998166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
    Wlaź P; Roliński Z; Czuczwar SJ
    Epilepsia; 1996 Jul; 37(7):610-7. PubMed ID: 8681892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.